等待開盤 02-05 09:30:00 美东时间
+0.440
+1.76%
Bowhead Specialty Holdings Inc. published an update to their financial calendar Bowhead Specialty Holdings Inc. will release its fourth quarter 2025 financial results on February 24, 2026, at approximately 7:00 a.m. Eastern Time. The earnings documents will be available on the Company's Investor Rel
01-28 20:00
The most oversold stocks in the financial sector presents an opportunity to buy...
01-20 19:24
今日重点评级关注:HC Wainwright & Co.:维持MetaVia Inc."买入"评级,目标价从12美元升至40美元;Canaccord Genuity:维持GH Research"买入"评级,目标价从35美元升至39美元
01-07 17:25
Keefe, Bruyette & Woods analyst Meyer Sheilds maintains Bowhead Specialty Hldgs (NYSE:BOW) with a Outperform and lowers the price target from $38 to $36.
01-07 01:19
今日重点评级关注:Ascendiant Capital:维持SurgePays Inc"买入"评级,目标价从9.5美元升至9.75美元;Ascendiant Capital:维持Outlook Therapeutics"买入"评级,目标价从8美元升至10美元
2025-12-23 12:32
Piper Sandler analyst Paul Newsome maintains Bowhead Specialty Hldgs (NYSE:BOW) with a Overweight and raises the price target from $30 to $32.
2025-12-22 20:46
Bowhead Specialty Holdings Inc. ( ($BOW) ) has issued an update. On November 26...
2025-12-02 06:18
Bowhead Specialty Holdings Inc. ( ($BOW) ) just unveiled an update. On November...
2025-11-26 06:23
今日重点评级关注:HC Wainwright & Co.:维持Oncolytics Biotech"买入"评级,目标价从5美元升至10美元;HC Wainwright & Co.:维持Barinthus Biotherapeutics"买入"评级,目标价从3美元升至4美元
2025-11-18 15:28
Morgan Stanley analyst Bob Huang maintains Bowhead Specialty Hldgs (NYSE:BOW) with a Equal-Weight and lowers the price target from $31 to $29.
2025-11-18 00:30